Opinion|Videos|November 26, 2024
Utilizing Antibiotics in Treatment of C Difficile
Author(s)Paul Feuerstadt, MD, FACG, AGAF
Key Takeaways
- Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI).
- New therapies like fecal microbiota transplantation (FMT) and monoclonal antibodies aim to restore healthy gut flora and provide targeted immune support.
The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections and a major risk factor for recurrence since they disrupt the protective gut microbiome, which led to the development of alternative therapies like fecal microbiota transplantation to restore microbial balance and prevent reinfection.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the role of antibiotics in the treatment of recurrent C difficile infections?
- Why was it necessary to develop new therapies beyond antibiotics?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance
2
Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog
3
Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD
4
PMOS Linked to 4-Fold Atherosclerotic Heart Disease Risk in 2.5 Million US Women
5